Raised $600M in Series C funding, led by Vitruvian Partners.
The company said the funding supports invest in its AI-native technology platform and navigation across hyper-local, condition-specific care.
The AfterRaise week
59 rounds, $4.2B of announced capital. The largest: Angle Health raised $600M. Sorted by size; every figure links to its source.
The company said the funding supports invest in its AI-native technology platform and navigation across hyper-local, condition-specific care.
The company said the funding supports accelerate its growth, deepen its international presence, and expand industrial and technological capabilities.
The company said the funding supports grow the capacity of its agentic data factory to meet demand and accelerate investment in vertical and enterprise AI.
The company said the funding supports advance ENV-294 and ENV-308 into later-stage trials and additional indications, advance ENV-6946 through mid-phase trials, bring additional medicines into clinical trials for inflammatory and metabolic conditions, and scale PRISM and the automated laboratory that feeds it.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports accelerate product development across all layers of its AI cloud, including inference, and multiply its compute capacity over the next year.
The announcement did not set out what the funding supports.
The company said the funding supports scale globally, invest in R&D, expand into new global markets, build out talent and processes, and launch interactive digital humans.
The announcement did not set out what the funding supports.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports expand its liquid credit facilities and warehouse lending lines, scale its core data science and risk-modeling engineering teams, strengthen automated regulatory compliance frameworks, and accelerate consumer user acquisition across North America.
The company said the funding supports accelerate product development and grow its team across engineering, sales, marketing, and product.
The company said the funding supports expand its research team, conduct frontier atmospheric research and expand operations globally.
The company said the funding supports expand the engineering team, accelerate development of both its software operating system, Go.OS, and hardware line, and scale its go-to-market efforts.
The company said the funding supports scale its go-to-market efforts and continue investing in the platform.
The company said the funding supports expand coverage for its library, Alexandria, deeper indexes and retrieval systems, direct connections to first-party sources, and payment infrastructure that allows knowledge contributors to earn from data used by AI agents.
The company said the funding supports complete its ongoing ATHENA pivotal IDE study, continue product development, and secure global regulatory approvals for its neurovascular portfolio.
The company said the funding supports accelerate product development, expand its presence in food service, and continue growing its product, engineering, and its go-to-market teams.
The company said the funding supports expand operations and its business reach.
The company said the funding supports increase production capacity for its Cypris platform, advance product development, expand engineering, commercial, and customer-support teams and build after-sales infrastructure.
The company said the funding supports expand operations and its business reach.
The company said the funding supports accelerate its expansion, advance multiple infrastructure projects, and invest in tools to evaluate and develop new sites faster through its AI-Accelerated Site Development Platform.
The company said the funding supports accelerate international expansion, expand its presence into the United States with a new office in Boston, deepen product capabilities, and scale deployments with life sciences organisations.
The company said the funding supports build its Zenith platform, accelerate product development across data and AI, expand its team with 50 new roles, and scale operations across Europe, the Americas, and Asia.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports further develop its proprietary legal action model, grow its legal engineering and product teams, and invest further in onboarding technology.
The announcement did not set out what the funding supports.
The announcement did not set out what the funding supports.
The company said the funding supports the commercial expansion in the United States and development of new high-value workflows for the intensive care unit and circulatory support settings, where time-critical imaging decisions directly shape patient management.
The company said the funding supports fuel its network of payor, health system, employer, provider, and brand partnerships, expand direct-purchase options, and support hiring across clinical, commercial, technology, and operational functions.
The company said the funding supports support R&D activities.
The company said the funding supports grow its team across product, engineering, and go-to-market roles, and to continue developing AI agents that guide borrowers through the consumer finance journey.
The announcement did not set out what the funding supports.
The announcement did not set out what the funding supports.
The company said the funding supports expand operations and its development efforts.
The company said the funding supports grow its sales organization, expand manufacturing capacity, and continue development of new products on the ArctiDry platform.
The company said the funding supports expand its international team by 50%, accelerate the development of its enterprise offering, and support growing demand from enterprise developers using Godot.
The announcement did not set out what the funding supports.
The company said the funding supports advance the clinical development of its Silkothane Arteriovenous Graft as a hemodialysis vascular access, and for preclinical development of the Silkothane® material in other vascular applications.
The company said the funding supports expand operations and platform development.
The Daily Brief
Every disclosed US, UK and European round of $5M or more, with what each company said the money supports, the morning it is observed. One email, only on days something happened, unsubscribe with one click.